Sexual fetishism

Pulse Biosciences Announces FDA Clearance for the CellFX® System

Retrieved on: 
Wednesday, February 3, 2021
Biotechnology, General Health, FDA, Medical devices, Health, Human sexuality, Sexology, Erotic electrostimulation, Masturbation, Sexual fetishism, LinkedIn Pulse, Sexuality

Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation (NPS) technology, today announced U.S. Food and Drug Administration (FDA) clearance of the CellFX System for dermatologic procedures requiring ablation and resurfacing of the skin.

Key Points: 
  • Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation (NPS) technology, today announced U.S. Food and Drug Administration (FDA) clearance of the CellFX System for dermatologic procedures requiring ablation and resurfacing of the skin.
  • FDA clearance for the CellFX System is a tremendous achievement for Pulse Biosciences.
  • Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the United States and other countries.
  • These statements are not historical facts but rather are based on Pulse Biosciences current expectations, estimates, and projections regarding Pulse Biosciences business, operations and other similar or related factors.

Pulse Biosciences Grants Equity Incentive Awards To New Employees

Retrieved on: 
Tuesday, December 15, 2020
Biotechnology, Pharmaceutical, Health, Medical devices, Human sexuality, Sexology, Erotic electrostimulation, Masturbation, Sexual fetishism, Pulse, Sexuality

Pulse Biosciences, Inc. (Nasdaq: PLSE) (Pulse Biosciences or the Company) a novel bioelectric medicine company progressing Nano-Pulse Stimulation (NPS) technology, today announced that the Compensation Committee of the Companys Board of Directors granted non-qualified stock options covering an aggregate of 40,250 shares of Pulse Biosciences common stock to recently hired non-executive employees under the Pulse Biosciences 2017 Inducement Equity Incentive Plan on December 15, 2020.

Key Points: 
  • Pulse Biosciences, Inc. (Nasdaq: PLSE) (Pulse Biosciences or the Company) a novel bioelectric medicine company progressing Nano-Pulse Stimulation (NPS) technology, today announced that the Compensation Committee of the Companys Board of Directors granted non-qualified stock options covering an aggregate of 40,250 shares of Pulse Biosciences common stock to recently hired non-executive employees under the Pulse Biosciences 2017 Inducement Equity Incentive Plan on December 15, 2020.
  • The options have an exercise price of $18.40 per share, which is equal to the closing price of Pulse Biosciences common stock on December 15, 2020.
  • Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve and extend the lives of patients.
  • Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the United States and other countries.

Pulse Biosciences Announces Receipt of MDSAP Certification

Retrieved on: 
Tuesday, September 29, 2020
Health, Medical devices, Technology, Nanotechnology, Pharmaceutical, Hardware, Biotechnology, Human sexuality, Articles, Magazines, Erotic electrostimulation, Masturbation, Sexual fetishism, Bioelectromagnetics, Pulse

Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation (NPS) technology, today announced the receipt of Medical Device Single Audit Program certification.

Key Points: 
  • Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation (NPS) technology, today announced the receipt of Medical Device Single Audit Program certification.
  • Certification through these programs validate our ongoing commitment to maintaining the highest quality assurance standards within the medical device industry as required by regulatory authorities across the world, said Darrin Uecker, President and CEO of Pulse Biosciences.
  • Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the United States and other countries.
  • These statements are not historical facts but rather are based on Pulse Biosciences current expectations, estimates, and projections regarding Pulse Biosciences business, operations and other similar or related factors.

Pulse Biosciences Grants Equity Incentive Awards To New Employees

Retrieved on: 
Tuesday, September 15, 2020
Biotechnology, Pharmaceutical, Health, Medical devices, Human sexuality, Sexuality, Erotic electrostimulation, Masturbation, Sexual fetishism, Pulse

Pulse Biosciences, Inc. (Nasdaq: PLSE) (Pulse Biosciences or the Company) a novel bioelectric medicine company progressing Nano-Pulse Stimulation (NPS) technology, today announced that the Compensation Committee of the Companys Board of Directors granted non-qualified stock options covering an aggregate of 77,250 shares of Pulse Biosciences common stock to recently hired non-executive employees under the Pulse Biosciences 2017 Inducement Equity Incentive Plan on September 15, 2020.

Key Points: 
  • Pulse Biosciences, Inc. (Nasdaq: PLSE) (Pulse Biosciences or the Company) a novel bioelectric medicine company progressing Nano-Pulse Stimulation (NPS) technology, today announced that the Compensation Committee of the Companys Board of Directors granted non-qualified stock options covering an aggregate of 77,250 shares of Pulse Biosciences common stock to recently hired non-executive employees under the Pulse Biosciences 2017 Inducement Equity Incentive Plan on September 15, 2020.
  • The options have an exercise price of $11.67 per share, which is equal to the closing price of Pulse Biosciences common stock on September 15, 2020.
  • Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve and extend the lives of patients.
  • Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the United States and other countries.

CAM4 Partners with King Noire & Jet Setting Jasmine to Launch Royal Fetish Radio Podcast Series

Retrieved on: 
Wednesday, September 9, 2020
Songs, Fetish subculture, Sexual fetishism, Sexuality and gender identity-based cultures, KinK, CAM4, KinK, Fetish, BDSM

LOS ANGELES, Sept. 9, 2020 /PRNewswire/ - CAM4 partnered with BDSM & fetish power couple, King Noire & Jet Setting Jasmine to launch Royal Fetish Radio: a podcast series that dives into the world of kink, fetish & pleasure as seen through their unique and unapologetic lens.

Key Points: 
  • LOS ANGELES, Sept. 9, 2020 /PRNewswire/ - CAM4 partnered with BDSM & fetish power couple, King Noire & Jet Setting Jasmine to launch Royal Fetish Radio: a podcast series that dives into the world of kink, fetish & pleasure as seen through their unique and unapologetic lens.
  • King & Jasmine are touted as thought leaders in the fetish space and outspoken advocates for their colleagues and sex work in general.
  • Their first episode, Love in Lockdown, premiered on Spotify , iTunes , and other major podcast networks as well as CAM4's SFW YouTube channel.
  • "I am so excited that CAM4 is taking on the challenge of catapulting Royal Fetish Radio to a larger audience," shares Jet Setting Jasmine.

Orthofix Announces FDA Approval of STIM onTrack 2.1 Mobile App for Bone Growth Stimulators

Retrieved on: 
Thursday, February 13, 2020
Data management, Medical devices, FDA, Health, Technology, Managed care, Human sexuality, Sexuality, Erotic electrostimulation, Masturbation, Sexual fetishism, Medical device, Mobile app, Medication related osteonecrosis of the jaw, Bone Growth Stimulators, Orthofix

(NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced the U.S. Food and Drug Administration (FDA) approval of the STIM onTrack mobile app version 2.1 for use with the Companys bone growth stimulators.

Key Points: 
  • (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced the U.S. Food and Drug Administration (FDA) approval of the STIM onTrack mobile app version 2.1 for use with the Companys bone growth stimulators.
  • View the full release here: https://www.businesswire.com/news/home/20200213005257/en/
    STIM onTrack 2.1 Mobile App for Bone Growth Stimulators (Photo: Business Wire)
    The STIM onTrack technology works with the Orthofix Bone Growth Therapy devices.
  • The mobile device app is an accessory designed to help patients adhere to their prescriptions and improve their clinical outcomes.
  • The STIM onTrack mobile app version 2.1 is an upgrade of the original STIM onTrack mobile app that was first introduced in 2017.

Royal Assent: Upskirting Bill signed into law

Retrieved on: 
Wednesday, February 13, 2019
Human sexuality, Sexual abuse, Sexual harassment, Sexual misconduct, Sexual ethics, Westminster system, Sexual fetishism, Upskirt, Royal assent, Voyeurism

The Voyeurism (Offences) (No.2) Bill receives Royal Assent

Key Points: 
  • The Voyeurism (Offences) (No.2) Bill, known colloquially as the Upskirting Bill,received Royal Assent on 12 February 2019.
  • It becomes the Voyeurism (Offences) Act 2019 and will come into force on 12 April2019.
  • The Act received Royal Asset on 12 February 2019, having completedall its parliamentary stages, and will come into force on 12 April 2019.
  • The Voyeurism (Offences) Act 2019: Parliamentary passage
    You can find explanatory information, bill documents, impartial supporting research and links to transcripts and video of proceedingsin both Houses of Parliament:

Royal Assent: Upskirting Bill signed into law

Retrieved on: 
Wednesday, February 13, 2019
Human sexuality, Sexual abuse, Sexual harassment, Sexual misconduct, Sexual ethics, Westminster system, Sexual fetishism, Upskirt, Royal assent, Voyeurism

The Voyeurism (Offences) (No.2) Bill receives Royal Assent

Key Points: 
  • The Voyeurism (Offences) (No.2) Bill, known colloquially as the Upskirting Bill,received Royal Assent on 12 February 2019.
  • It becomes the Voyeurism (Offences) Act 2019 and will come into force on 12 April2019.
  • The Act received Royal Asset on 12 February 2019, having completedall its parliamentary stages, and will come into force on 12 April 2019.
  • The Voyeurism (Offences) Act 2019: Parliamentary passage
    You can find explanatory information, bill documents, impartial supporting research and links to transcripts and video of proceedingsin both Houses of Parliament:

InventHelp Inventor Develops Accessory for Parents Carrying Children's Cups/Beverages (MTN-3017)

Retrieved on: 
Friday, September 7, 2018
Sexual fetishism, Paraphilias, Pornography, Wet and messy fetishism, Fashion, Culture, Human behavior

She developed the SAVVY MOMMY to protect the interior of a bag from getting wet and messy as a result of carrying cups and beverages.

Key Points: 
  • She developed the SAVVY MOMMY to protect the interior of a bag from getting wet and messy as a result of carrying cups and beverages.
  • The accessory enables a parent or caregiver to carry a fashionable bag without having to worry about the interior getting wet.
  • The original design was submitted to the Manhattan office of InventHelp.
  • 17-MTN-3017, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext.

New Revenge Thriller Novel Explores Darkest Side of Battle Between "Wife Versus Mistress"

Retrieved on: 
Thursday, June 28, 2018
Eupitheciini, Human sexuality, Catfight, Fetish subculture, Sexual fetishism, Carbia, Twist, Software

The names sound familiar, as well as the story of two women sharing the same man in different roles.

Key Points: 
  • The names sound familiar, as well as the story of two women sharing the same man in different roles.
  • "Think 'Real Housewives' meets 'Misery' but with a fantastic twist ending you won't see coming," says Mark Miller from Top10Novels.com.
  • The book's female author, Mylo Carbia, makes no apologies for writing a novel advertised as The Ultimate Catfight.
  • Luckily, Carbia has completely bounced back, with another bestselling novel and plans to marry her new husbandretired Navy war veteran, Kurt Lundthis September.